vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $40.3M, roughly 1.5× Cambium Networks Corp). Cambium Networks Corp runs the higher net margin — -17.9% vs -70.9%, a 53.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -23.2%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-10.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CMBM vs CTKB — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $62.1M |
| Net Profit | $-7.2M | $-44.1M |
| Gross Margin | 36.6% | 52.9% |
| Operating Margin | -28.4% | -9.0% |
| Net Margin | -17.9% | -70.9% |
| Revenue YoY | -23.2% | 8.1% |
| Net Profit YoY | 71.0% | -557.1% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.1M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | — | $41.5M | ||
| Q4 24 | $40.3M | $57.5M | ||
| Q3 24 | $44.7M | $51.5M | ||
| Q2 24 | $45.2M | $46.6M | ||
| Q1 24 | $47.1M | $44.9M |
| Q4 25 | — | $-44.1M | ||
| Q3 25 | — | $-5.5M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | $-7.2M | $9.6M | ||
| Q3 24 | $-34.5M | $941.0K | ||
| Q2 24 | $-14.2M | $-10.4M | ||
| Q1 24 | $-18.4M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | 36.6% | 58.5% | ||
| Q3 24 | 43.6% | 56.3% | ||
| Q2 24 | 32.5% | 54.6% | ||
| Q1 24 | 29.8% | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | — | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | -28.4% | 5.2% | ||
| Q3 24 | -69.6% | -8.2% | ||
| Q2 24 | -27.2% | -18.3% | ||
| Q1 24 | -33.1% | -23.9% |
| Q4 25 | — | -70.9% | ||
| Q3 25 | — | -10.5% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -27.5% | ||
| Q4 24 | -17.9% | 16.8% | ||
| Q3 24 | -77.3% | 1.8% | ||
| Q2 24 | -31.5% | -22.4% | ||
| Q1 24 | -39.2% | -13.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-1.22 | — | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | $67.6M | — |
| Stockholders' EquityBook value | $-3.2M | $341.7M |
| Total Assets | $173.7M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $67.6M | — | ||
| Q3 24 | $67.6M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | — |
| Q4 25 | — | $341.7M | ||
| Q3 25 | — | $378.6M | ||
| Q2 25 | — | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | $-3.2M | $395.7M | ||
| Q3 24 | $1.9M | $385.5M | ||
| Q2 24 | $34.1M | $389.1M | ||
| Q1 24 | $45.0M | $392.6M |
| Q4 25 | — | $461.5M | ||
| Q3 25 | — | $494.9M | ||
| Q2 25 | — | $493.3M | ||
| Q1 25 | — | $482.6M | ||
| Q4 24 | $173.7M | $499.5M | ||
| Q3 24 | $194.3M | $491.2M | ||
| Q2 24 | $221.1M | $483.7M | ||
| Q1 24 | $219.8M | $492.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-771.0K |
| Free Cash FlowOCF − Capex | $-10.8M | $-1.8M |
| FCF MarginFCF / Revenue | -26.8% | -2.9% |
| Capex IntensityCapex / Revenue | 1.1% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-771.0K | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $108.0K | ||
| Q1 25 | — | $-125.0K | ||
| Q4 24 | $-10.4M | $2.0M | ||
| Q3 24 | $8.9M | $13.2M | ||
| Q2 24 | $2.4M | $6.2M | ||
| Q1 24 | $-15.9M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | $-10.8M | $1.1M | ||
| Q3 24 | $6.8M | $12.2M | ||
| Q2 24 | $87.0K | $5.2M | ||
| Q1 24 | $-17.4M | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | -26.8% | 1.9% | ||
| Q3 24 | 15.2% | 23.7% | ||
| Q2 24 | 0.2% | 11.0% | ||
| Q1 24 | -37.0% | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | 1.1% | 1.6% | ||
| Q3 24 | 4.8% | 2.0% | ||
| Q2 24 | 5.1% | 2.3% | ||
| Q1 24 | 3.3% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
